ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 245 filers reported holding ISIS PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 1.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $5,005,000 | -44.9% | 123,821 | -21.6% | 0.01% | -38.5% |
| Q2 2015 | $9,091,000 | -47.3% | 157,975 | -41.7% | 0.01% | -45.8% |
| Q1 2015 | $17,259,000 | +78.0% | 271,078 | +72.6% | 0.02% | +71.4% |
| Q4 2014 | $9,697,000 | +7359.2% | 157,065 | +4567.6% | 0.01% | – |
| Q3 2014 | $130,000 | -23.5% | 3,365 | -31.8% | 0.00% | – |
| Q2 2014 | $170,000 | -95.3% | 4,935 | -94.1% | 0.00% | -100.0% |
| Q1 2014 | $3,607,000 | -25.1% | 83,480 | -31.0% | 0.01% | -25.0% |
| Q4 2013 | $4,818,000 | +3522.6% | 120,924 | +3318.8% | 0.01% | – |
| Q3 2013 | $133,000 | +40.0% | 3,537 | 0.0% | 0.00% | – |
| Q2 2013 | $95,000 | – | 3,537 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,417,548 | $255,675,000 | 13.66% |
| HWG Holdings LP | 339,799 | $13,538,000 | 8.73% |
| DOWLING & YAHNKE LLC | 675,798 | $26,924,000 | 3.78% |
| GARRISON BRADFORD & ASSOCIATES INC | 99,300 | $3,956,000 | 3.74% |
| WILLIAM HARRIS INVESTORS INC | 283,834 | $11,308,000 | 3.35% |
| SECTORAL ASSET MANAGEMENT INC | 1,222,401 | $48,700,000 | 2.10% |
| AVALON CAPITAL MANAGEMENT | 49,999 | $1,992,000 | 1.68% |
| PINNACLE ASSOCIATES LTD | 2,016,369 | $80,332,000 | 1.57% |
| PERKINS CAPITAL MANAGEMENT INC | 48,515 | $1,933,000 | 1.30% |
| NCM Capital Advisers, Inc. | 31,100 | $1,239,000 | 1.28% |